Pretraži

U Ugovoru iz Lisabona daje se veća važnost zdravstvenoj politici te se navodi da se „u utvrđivanju i provedbi svih politika i aktivnosti Unije osigurava visok stupanj zaštite zdravlja ljudi”. Taj se cilj može ostvariti podrškom Unije državama članicama i poticanjem suradnje. Glavnu odgovornost za zaštitu zdravlja, a posebno za zdravstvene sustave, i dalje imaju države članice. No Europska unija ima važnu ulogu u poboljšanju javnog zdravlja, sprečavanju i upravljanju bolesti, ublažavanju izvora opasnosti ...

Lijekovi i medicinski proizvodi podliježu pravilima jedinstvenoga tržišta te je za njihovo odobrenje nadležna Europska unija, koja izrađuje procjene i provodi nadzor. Radi zaštite javnoga zdravlja, Europska agencija za lijekove (EMA) u okviru centraliziranog postupka i/ili nacionalne agencije na decentraliziran način odobravaju nove farmaceutske proizvode za ljudsku uporabu prije nego što se oni stave na tržište. Medicinski proizvodi iziskuju detaljni regulatorni okvir za pristup tržištu preko organizacija ...

This compilation of briefings presents the most salient points and essential commitments made by the commissioners-designate during the hearings held in September/October 2014 before the parliamentary committees. These commitments concern the main on-going legislative procedures, the preparation of future legislative proposals as well as the scrutiny of the implementation of existing legislation. They also touch upon the crucial issue of inter-institutional cooperation.

Briefing summarises commitments made at the hearing of Vytenis Andriukaitis Commissioner designate for Health & Food Safety.

Briefing summarises commitments made at the hearing Miguel Arias Cañete Commissioner designate for Climate Action & Energy.

Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern ...

For many years the health consequences of new legislation have been taken into account during the policy formulation process in areas such as agriculture, environment, food and others. The inclusion of Health in All Policies is now enshrined in the Lisbon Treaty (Art. 168). The aim of the workshop was to present an update on how the system is actually functioning within the different Commission services. Several DGs representatives, led by DG SANCO, made contributions. The case of The Netherlands ...